Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway
This study demonstrates that the NRF2 pathway may serve as a therapeutic target in NSCLC, and ginseng compounds may be effective for the treatment of this disease.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Preclinical Papers Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Genetics | Ginseng | Lung Cancer | Multidrug Resistance | Non-Small Cell Lung Cancer | Study